Anti-obesity and Antidiabetic Effects of Deep Sea Water on ob/ob Mice

被引:0
|
作者
Hee Sun Hwang
Hyun Ah Kim
Sung Hak Lee
Jong Won Yun
机构
[1] Daegu University,Department of Biotechnology
来源
Marine Biotechnology | 2009年 / 11卷
关键词
Adipocytes; Adipogenesis; Antidiabetes; Anti-obesity; Deep sea water;
D O I
暂无
中图分类号
学科分类号
摘要
Recently, deep sea water (DSW) has started to receive much attention for therapeutic intervention in some lifestyle diseases. In this study, the anti-obesity and antidiabetic effects of DSW in ob/ob mice were investigated. The animals were randomly divided into two groups with six animals: control group received tap water; the experimental group was treated with DSW of hardness 1000 for 84 days. The body weight gain after 84 days in DSW-fed group was decreased by 7% compared to the control group. The plasma glucose levels in the DSW-fed mice were substantially reduced by 35.4%, as compared to control mice. The results of oral glucose tolerance test revealed that DSW-fed groups significantly increased the glucose disposal after 84 days. DSW increased plasma protein levels of adiponectin and decreased plasma protein levels of resistin, RBP4, and fatty acid binding protein. Moreover, GLUT4 and AMP-activated protein kinase levels in skeletal muscle tissue were increased while peroxisome proliferator-activated receptor γ and adiponectin were decreased in adipose tissue of DSW-fed mice. These results suggest that the antidiabetic and anti-obesity activities of DSW were mediated by modulating the expression of diabetes- and obesity-specific molecules. Taken together, these results provide a possibility that continuous intake of DSW can ameliorate obesity and diabetes.
引用
收藏
相关论文
共 50 条
  • [21] Antidiabetic Properties of Zinc-α2-Glycoprotein in ob/ob Mice
    Russell, Steven T.
    Tisdale, Michael J.
    ENDOCRINOLOGY, 2010, 151 (03) : 948 - 957
  • [22] ACTIONS OF NOVEL ANTIDIABETIC AGENT ENGLITAZONE IN HYPERGLYCEMIC HYPERINSULINEMIC OB/OB MICE
    STEVENSON, RW
    HUTSON, NJ
    KRUPP, MN
    VOLKMANN, RA
    HOLLAND, GF
    EGGLER, JF
    CLARK, DA
    MCPHERSON, RK
    HALL, KL
    DANBURY, BH
    GIBBS, EM
    KREUTTER, DK
    DIABETES, 1990, 39 (10) : 1218 - 1227
  • [23] PN2022: Antidiabetic efficacy and reversal of steatohepatitis in ob/ob mice
    Hodge, K
    Sharma, S
    Kirassova, M
    Song, XL
    Lu, M
    Wolpe, S
    Von Borstel, R
    DIABETES, 2002, 51 : A139 - A139
  • [24] Mitochondrial Dynamic and Dysfunction in OB/OB Mice With Obesity and Diabetes
    Finocchietto, Paola V.
    Pagnini, Maria C.
    Holod, Silvia A.
    Peralta, Jorge G.
    Alippe, Yael
    Carreras, Maria C.
    Poderoso, Juan J.
    DIABETES, 2013, 62 : A530 - A530
  • [25] Taurine Ameliorates Obesity by Improving Lipogenesis in ob/ob Mice
    Yim, Jung-Eun
    Bae, Minkyung
    Choi, Ha Neul
    Ahmed, Kainat
    OBESITY, 2021, 29 : 169 - 169
  • [26] DEVELOPMENT OF OBESITY, HYPERINSULINEMIA, AND HYPERGLYCEMIA IN OB-OB MICE
    DUBUC, PU
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1976, 25 (12): : 1567 - 1574
  • [27] OBESITY MINIMIZES THE IMMUNOPOTENTIATION OF FOOD RESTRICTION IN OB/OB MICE
    BOISSONNEAULT, GA
    HARRISON, DE
    JOURNAL OF NUTRITION, 1994, 124 (09): : 1639 - 1646
  • [28] ADRENALECTOMY REDUCES BUT DOES NOT REVERSE OBESITY IN OB OB MICE
    DUBUC, PU
    WILDEN, NJ
    INTERNATIONAL JOURNAL OF OBESITY, 1986, 10 (02) : 91 - 98
  • [29] Anti-obesity effect of a standardised ethanol extract from Curcuma longa L. fermented with Aspergillus oryzae in ob/ob mice and primary mouse adipocytes
    Ho, Jin-Nyoung
    Jang, Ja Young
    Yoon, Ho-Geun
    Kim, Yongjae
    Kim, Sunoh
    Jun, Woojin
    Lee, Jeongmin
    JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE, 2012, 92 (09) : 1833 - 1840
  • [30] Antidiabetic effect of a novel non-thiazolidinedione PPAR γ/α agonist on ob/ob mice
    Xi HU Ying FENG Yu SHEN Xiao-feng ZHAO Juan-hong YU Yu-she YANG Ying LENG~2 Shanghai Institute of Materia Medica
    ActaPharmacologicaSinica, 2006, (10) : 1346 - 1352